Tiziana Life Sciences (TLSA) insider awarded 42,357 shares of common stock

Rhea-AI Filing Summary

Tiziana Life Sciences Ltd reported that director and ten percent owner Gabriele M. Cerrone, holding indirectly via Panetta Partners Limited, received a grant/award of 42,357 shares of common stock on July 21, 2026 at $0.99 per share. Following this indirect acquisition, his associated holdings total 44,814,587 common shares.

Insider Trade Summary

Net Buyer: 42,357 shares

Net Buy 1 txn

Insider CERRONE GABRIELE M

Role Director, 10% Owner

Type	Security	Shares	Price	Value
Grant/Award	COMMON STOCK	42,357	$0.99	$42K

Holdings After Transaction: COMMON STOCK — 44,814,587 shares (Indirect, Via Panetta Partners Limited)

Key Figures

Shares acquired: 42,357 shares of common stock Award price: $0.99 per share Holdings after transaction: 44,814,587 common shares

3 metrics

Shares acquired 42,357 shares of common stock Grant/award acquisition on July 21, 2026

Award price $0.99 per share Value per share for the 42,357-share grant/award

Holdings after transaction 44,814,587 common shares Indirect ownership via Panetta Partners Limited following the award

Key Terms

indirect ownership, grant/award acquisition, ten percent owner

3 terms

indirect ownership financial

"reported as indirect ownership via Panetta Partners Limited"

grant/award acquisition financial

"transaction is classified as a grant/award acquisition of shares"

ten percent owner financial

"Gabriele M. Cerrone is listed as a ten percent owner"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/23/2026 - 04:16 PM Accepted by SEC EDGAR 07/23/2026 - 04:15 PM Learn about SEC filing dates

FAQ

What insider transaction did TLSA disclose for Gabriele M. Cerrone?

Tiziana Life Sciences Ltd disclosed that Gabriele M. Cerrone received a grant/award of 42,357 common shares. The shares were acquired indirectly via Panetta Partners Limited on July 21, 2026, rather than through an open-market purchase or sale.

At what price were the new TLSA shares attributed to Gabriele M. Cerrone?

The newly awarded TLSA shares were valued at $0.99 per share. This price applies to the 42,357 common shares received as a grant/award on July 21, 2026, and does not represent a reported open-market trading price.

How many TLSA shares does Gabriele M. Cerrone hold after this transaction?

After the reported award, entities associated with Gabriele M. Cerrone hold 44,814,587 TLSA common shares. These shares are reported as held indirectly via Panetta Partners Limited, reflecting his status as both a director and ten percent owner.

Is the TLSA insider position held directly or indirectly by Gabriele M. Cerrone?

The reported TLSA position is held indirectly by Gabriele M. Cerrone. The Form 4 specifies ownership "Via Panetta Partners Limited", indicating the shares are attributed through that entity rather than direct personal registration.

What type of Form 4 transaction was reported for TLSA’s Gabriele M. Cerrone?

The transaction is classified as a grant, award, or other acquisition of common stock. It covers 42,357 shares and is coded as an acquisition (code A), rather than a market purchase (P) or sale (S) of TLSA shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CERRONE GABRIELE M

(Last) (First) (Middle)

14-15 CONDUIT ST

(Street)

LONDON W1S2XJ

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Tiziana Life Sciences Ltd [ TLSA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
COMMON STOCK	07/21/2026		A		42,357	A	$0.99	44,814,587	I	Via Panetta Partners Limited

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Gabriele M. Cerrone	07/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)